SCHEMBL348122

SCHEMBL348122

NC(=O)Oc1ccc(O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
PARP10 Q53GL7 1/20 0.54
KIF11 P52732 1/20 0.52
GAA P10253 3/20 0.48
MAPT P10636 3/20 0.48
KDM4E B2RXH2 1/20 0.48
GLA P06280 1/20 0.48
THRB P10828 1/20 0.48
BLM P54132 1/20 0.48
CASP6 P55212 1/20 0.48
GFER P55789 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
ESR1 P03372 2/20 0.48
ESR2 Q92731 2/20 0.48
ELANE P08246 3/20 0.47
XBP1 P17861 1/20 0.46
CA2 P00918 1/20 0.43
PEPD P12955 1/20 0.43
LTA4H P09960 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6284986 0.89 KMT2A (0.64) MEN1KMT2APARP10KIF11MAPT
SCHEMBL28923975 0.83 MAPT (0.55) MEN1KMT2AGAAMAPTKDM4E
SCHEMBL1850368 0.80 KMT2A (0.54) MEN1KMT2APARP10KIF11GAA
SCHEMBL5697552 0.79 MEN1 (0.59) MEN1KMT2APARP10KIF11GAA
SCHEMBL10356467 0.79 ESR2 (0.52) MEN1KMT2APARP10GAAMAPT
SCHEMBL5683906 0.79 MEN1 (0.52) MEN1KMT2APARP10GAAMAPT
SCHEMBL14817188 0.79 ESR1 (0.62) MEN1KMT2AKIF11GAAMAPT
SCHEMBL936193 0.78 MEN1 (0.52) MEN1KMT2AKIF11MAPTCA2
SCHEMBL473211 0.78 LMNA (0.64) MEN1KMT2APARP10KIF11GAA
SCHEMBL22923566 0.78 KMT2A (0.52) MEN1KMT2APARP10KIF11MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114644563-B Diamine monomer containing aromatic ester group and symmetric fluorobenzene structure as well as preparation method and application thereof 四川大学 2023-04-07 CN claimed
CN-115197130-A Aryl urea derivative and preparation method and application thereof 安徽医科大学 2022-10-18 CN claimed
CN-114644563-A Diamine monomer containing aromatic ester group and symmetric fluorobenzene structure as well as preparation method and application thereof 四川大学 2022-06-21 CN claimed
US-8207229-B1 Preparation of hydroquinone amide compounds with antioxidant properties CATALYS SAS (FR) 2012-06-26 US claimed
US-8003824-B2 Preparation of hydroquinone amide compounds with antioxidant properties CATALYS SAS (FR) 2011-08-23 US claimed
EP-2257523-B1 PREPARATION OF HYDROQUINONE AMIDE COMPOUNDS WITH ANTIOXIDANT PROPERTIES CATALYS SAS (FR) 2011-08-10 EP claimed
US-20110021820-A1 Preparation of Hydroquinone Amide Compounds with Antioxidant Properties CATALYS SAS (FR) 2011-01-27 US claimed
EP-2257523-A2 PREPARATION OF HYDROQUINONE AMIDE COMPOUNDS WITH ANTIOXIDANT PROPERTIES. Catalys Sas (FR) 2010-12-08 EP claimed
EP-2197921-A1 METHOD OF MAKING CARBAMATE FUNCTIONAL MATERIALS BASF Coatings GmbH (US) 2010-06-23 EP claimed
WO-2009115707-A2 PREPARATION OF HYDROQUINONE AMIDE COMPOUNDS WITH ANTIOXIDANT PROPERTIES. CATALYS SAS (FR) 2009-09-24 WO claimed
WO-2009035667-A1 METHOD OF MAKING CARBAMATE FUNCTIONAL MATERIALS BASF CORPORATION (US) 2009-03-19 WO claimed
CN-118307534-A LTA4H inhibitors and uses thereof 上海海雁医药科技有限公司 2024-07-09 CN disclosed
CN-118302204-A Macrocyclic compounds and diagnostic uses thereof 詹森生物科技公司 2024-07-05 CN disclosed
CN-118206542-A Compound, preparation method thereof and application of compound in preparation of sEH inhibitor and PPARs agonist 沈阳药科大学 2024-06-18 CN disclosed
CN-118206473-A Compound, preparation method thereof and application of compound in preparation of sEH inhibitor and PPARs agonist 沈阳药科大学 2024-06-18 CN disclosed
EP-0807625-B1 4-(n,n-Dialkylamino)Aniline compounds, photographic processing composition containing the same and color image-forming method FUJI PHOTO FILM CO LTD (JP) 2002-08-21 EP disclosed
US-5994546-A 4-(N,N-DIALKYLAMINO)ANILINE COMPOUNDS HAVING A 4-N SUBSTITUENT WHICH IS A POLYETHYLENEOXY GROUP AND WHICH FORMS A CONDENSED RING WITH BENZENE RING FUJI PHOTO FILM CO., LTD. (JP) 1999-11-30 US disclosed
US-5773203-A 4-(N,N-dialkylamino)aniline compounds, photographic processing composition containing the same and color image-forming method FUJI PHOTO FILM CO., LTD. (JP) 1998-06-30 US disclosed
US-5721093-A DEVELOPER IS A 7-AMINOINDOLE COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 1998-02-24 US disclosed
EP-0807625-A1 4-(n,n-Dialkylamino)Aniline compounds, photographic processing composition containing the same and color image-forming method FUJI PHOTO FILM CO., LTD. (JP) 1997-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021820-A1 Preparation of Hydroquinone Amide Compounds with Antioxidant Properties NQO1, TYR, AHR MEN1 4515/4885KMT2A 1182/4885PARP10 3890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.